Skip to main content

Table 3 Predictive accuracy of baseline risk model and the addition of three individual lipid derivatives for gastric cancer mortality in both derivation and validation groups

From: Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study

Statistics Derivation group (n = 1506) Validation group (n = 1506)
BR-Model (BRM) BRM plus AI BRM plus THR BRM plus LHR BR-Model (BM) BRM plus AI BRM plus THR BRM plus LHR
AIC 2476 2461 2473 2458 2604 2584 2599 2586
BIC 2532 2523 2531 2519 2660 2645 2660 2647
LR test: [Chi]2 Reference 16.26 4.9 17.85 Reference 12.58 5.34 12.55
LR test: P Reference 0.0001 0.0269 < 0.0001 Reference 0.0004 0.0208 0.0004
Harrell’s C 0.7662 0.7693 0.7679 0.7697 0.7541 0.7587 0.7555 0.7579
  1. BR-Model included age, gender, smoking, drinking, family cancer history, body mass index, systolic blood pressure, diastolic blood pressure, fasting blood glucose, tumor-node-metastasis stage, tumor size, Lauren’s classification, number of lymph node metastasis and tumor embolus
  2. Abbreviations: BR-Model (BRM) baseline risk model (BRM), AI atherogenic index, THR the triglyceride to high-density lipoprotein cholesterol ratio, LHR the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio, AIC Akaike information criterion, BIC Bayesian information criteria, LR test likelihood ratio test